About Andrew Levin
Form D filings for Aktis Oncology in 2024 list Andrew Levin as director.
Andrew Levin first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name Andrew Levin in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Andrew Levin works with at each company, as listed on that company's latest Form D.
Aktis Oncology, Inc. · Form D, Oct 2, 2024
HK
Helen Kim
Director
SB
Shulamit Ron-Bigger
Executive officer
KH
Ken Herrmann
Director
LS
Lloyd Segal
Director
ON
Oleg Nodelman
Director
MR
Matthew Roden
CEO and director
TF
Todd Foley
Director